X hits on this document

112 views

0 shares

0 downloads

0 comments

27 / 41

Evaluation of STI policies - L. BACH

27

But DIFFICULTIES related to the very nature of R&D activities…

uncertainty, long term, spreading, multiplicity of actors and factors…

…to the scope of effects …

which actors, intangible effects …

…to the type of STI policy

fundings, IPR regulation, nteworking

<=> linear model- "input/output" – private vs social rate of return

Dominant models (5)

« Downstream » (market…)

Cost-benefit analysis

Ex. :

-products / process services derived

-sales of R&D services, tests, technical assistance

-revenues from the commercialisation of R&D results (technologies, patents,…)

Document info
Document views112
Page views112
Page last viewedMon Jan 16 13:21:07 UTC 2017
Pages41
Paragraphs574
Words2810

Comments